JP2002201126A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002201126A5 JP2002201126A5 JP2001388117A JP2001388117A JP2002201126A5 JP 2002201126 A5 JP2002201126 A5 JP 2002201126A5 JP 2001388117 A JP2001388117 A JP 2001388117A JP 2001388117 A JP2001388117 A JP 2001388117A JP 2002201126 A5 JP2002201126 A5 JP 2002201126A5
- Authority
- JP
- Japan
- Prior art keywords
- menthol
- content
- sodium cromoglycate
- antihistamine
- eye
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 6
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 6
- 229940041616 menthol Drugs 0.000 description 6
- 229960000265 cromoglicic acid Drugs 0.000 description 5
- IMZMKUWMOSJXDT-UHFFFAOYSA-N cromoglycic acid Chemical compound O1C(C(O)=O)=CC(=O)C2=C1C=CC=C2OCC(O)COC1=CC=CC2=C1C(=O)C=C(C(O)=O)O2 IMZMKUWMOSJXDT-UHFFFAOYSA-N 0.000 description 5
- 239000000739 antihistaminic agent Substances 0.000 description 4
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 3
- 230000001387 anti-histamine Effects 0.000 description 3
- 239000003889 eye drop Substances 0.000 description 3
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 description 1
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 description 1
- 206010015958 Eye pain Diseases 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 229940046978 chlorpheniramine maleate Drugs 0.000 description 1
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 239000002997 ophthalmic solution Substances 0.000 description 1
- 229940054534 ophthalmic solution Drugs 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001388117A JP4695315B2 (ja) | 1996-09-26 | 2001-12-20 | 点眼剤 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1996255198 | 1996-09-26 | ||
| JP25519896 | 1996-09-26 | ||
| JP8-255198 | 1996-09-26 | ||
| JP2001388117A JP4695315B2 (ja) | 1996-09-26 | 2001-12-20 | 点眼剤 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP51550898A Division JP3402613B2 (ja) | 1996-09-26 | 1997-09-26 | 点眼剤 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007294474A Division JP2008110981A (ja) | 1996-09-26 | 2007-11-13 | 点眼剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002201126A JP2002201126A (ja) | 2002-07-16 |
| JP2002201126A5 true JP2002201126A5 (https=) | 2007-06-14 |
| JP4695315B2 JP4695315B2 (ja) | 2011-06-08 |
Family
ID=26542079
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001388117A Expired - Lifetime JP4695315B2 (ja) | 1996-09-26 | 2001-12-20 | 点眼剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4695315B2 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005239681A (ja) * | 2004-02-27 | 2005-09-08 | Taisho Pharmaceut Co Ltd | 眼科用剤 |
| EP1946753A4 (en) * | 2005-10-21 | 2009-05-13 | Medrx Co Ltd | PREPARATION FOR TOPICAL APPLICATION WITH A SALT OF A MAST CELL DEGRANULATION INHIBITOR WITH A CARBOXY GROUP WITH ORGANIC AMINE |
| JP4777477B2 (ja) | 2009-09-30 | 2011-09-21 | ロート製薬株式会社 | 点眼剤 |
-
2001
- 2001-12-20 JP JP2001388117A patent/JP4695315B2/ja not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1426375A3 (en) | Analgesic spiroindole derivatives | |
| WO2002085248A3 (en) | Prostanoids augment ocular drug penetration | |
| CA2458067A1 (en) | Use of flibanserin in the treatment of sexual disorders | |
| DK1553927T3 (da) | Gel-stabiliserede, nanopartikulære aktivstof-sammensætninger | |
| MXPA05008909A (es) | Formulacion intranasal de rotigotina. | |
| WO2004056337A3 (en) | Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats | |
| JP2004510493A5 (https=) | ||
| DE60223254D1 (de) | Verzögert freisetzende formulierungen von oxymorphon | |
| JP2004537500A5 (https=) | ||
| JP2003504332A5 (https=) | ||
| MXPA03003741A (es) | Metodos y composiciones para el tratamiento de enfermedades oftalmicas. | |
| EP1262197A3 (en) | Combination treatment for sleep disorders including sleep apnea | |
| WO2002051379A3 (en) | Thixotropic nasal spray | |
| JP2002114686A5 (https=) | ||
| JP2002201126A5 (https=) | ||
| WO2002053149A3 (de) | Arzneimittel enthaltend ein polyamin als wirksubstanz | |
| WO2004018044A3 (en) | N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-'1,3,4-oxadiazol-2-yl!phenyl)pyridine-3 sulphonamide as an anticancer agent | |
| SE0000303D0 (sv) | Novel compounds | |
| WO2002053099A3 (en) | Methods and compositions for treating periodontal disease | |
| ATE481971T1 (de) | Formulierung von 3-amino-8-(1-piperazinyl)-2h- 1benzopyran-2-on mit verzögerter freisetzung | |
| JP2002325828A5 (https=) | ||
| CA2436537A1 (en) | Pharmaceutical compositions comprising tiotropium salts and antihistamines | |
| AU9184901A (en) | Use of il-6r/il-6 chimera in huntington's disease | |
| BR0108732A (pt) | Composição farmacêutica para a prevenção e tratamento da progressão da fibrose e cirrose hepática, seu uso e método para a prevenção e tratamento da fibrose e cirrose hepática | |
| MEP39708A (en) | New pharmaceutical compositions containing epinastine and pseudoephedrine |